Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Reata Pharmaceuticals Inc
About RETA
Reata Pharmaceuticals, Inc. is a biopharmaceutical company focused on identifying, developing, and commercializing therapies. The Company concentrates on small-molecule therapeutics with mechanisms of action for the treatment of severe, life-threatening diseases with few or no approved therapies. The Company's first product, SKYCLARYS (omaveloxolone), is used for the treatment of Friedreich's ataxia (FA) in adults and adolescents aged 16 years and older. It is also engaged in developing cemdomespib, the lead product candidate from its Hsp90 modulator program, in neurological indications and Nrf2 activators for neurological diseases. Omaveloxolone activates the transcription factor Nrf2 to normalize mitochondrial function, restore redox balance, and resolve inflammation, in nonclinical models. Its Nrf2 activators are applicable to both rare diseases, such as Huntington's disease, progressive supranuclear palsy, frontotemporal dementia, primary progressive multiple sclerosis, and others.
Find out what a historical investment in Reata Pharmaceuticals Inc would be worth today using our RETA stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy RETA shares in Australia?
Buying RETA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Reata Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RETA
What is the ticker symbol of Reata Pharmaceuticals Inc?
The ticker symbol for Reata Pharmaceuticals Inc is RETA.
How much is one share of RETA?
One share of RETA is valued at $169.22 as of 20 May 2026.
What is the market capitalisation of Reata Pharmaceuticals Inc RETA?
As of 20 May 2026 Reata Pharmaceuticals Inc has a market cap of -.
What is the 52-week high for Reata Pharmaceuticals Inc stock?
The Reata Pharmaceuticals Inc 52-week high stock price is $NaN.
What is the 52-week low for Reata Pharmaceuticals Inc stock?
The Reata Pharmaceuticals Inc 52-week low stock price is $NaN.
Can I buy RETA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RETA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RETA on Stake
- Buy RETA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RETA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RETA related stocks